Advanced Biomed Inc. (NASDAQ:ADVB) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 13, 2026.
The Healthcare company reported Q0 revenue of .
Advanced Biomed Inc.'s stock currently trades at $0.24 with a market capitalization of $7.8M.